Senior insider sale
Chief Commercial Officer at ARS PHARMACEUTICALS, INC. — senior position signals high conviction
$494.9K
30K shares
What this filing means
KARAS ERIC plans to sell 30K shares of ARS PHARMACEUTICALS, INC. valued at approximately $494.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2025ACC: 0001950047-25-004740
Officer· Chief Commercial Officer
Since Nov 2022
30K
Shares to sell
$494.9K
Approx. market value
15K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/1/2025
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2025 | Stock Option Exercise Cash | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
15K
Market value
$240.0K
6/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
15K
Market value
$254.9K
7/1/2025
Total
Units
30K
Value
$494.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/18/2025 | 15K | $240.0K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2025 | 15K | $254.9K | NASDAQ | Planned |
| Total | 30K | $494.9K | ||